169 related articles for article (PubMed ID: 27897199)
1. Hydroxychavicol: A phytochemical targeting cutaneous fungal infections.
Ali I; Satti NK; Dutt P; Prasad R; Khan IA
Sci Rep; 2016 Nov; 6():37867. PubMed ID: 27897199
[TBL] [Abstract][Full Text] [Related]
2. In vitro antifungal activity of hydroxychavicol isolated from Piper betle L.
Ali I; Khan FG; Suri KA; Gupta BD; Satti NK; Dutt P; Afrin F; Qazi GN; Khan IA
Ann Clin Microbiol Antimicrob; 2010 Feb; 9():7. PubMed ID: 20128889
[TBL] [Abstract][Full Text] [Related]
3. In vitro antifungal activity of KP-103, a novel triazole derivative, and its therapeutic efficacy against experimental plantar tinea pedis and cutaneous candidiasis in guinea pigs.
Tatsumi Y; Yokoo M; Arika T; Yamaguchi H
Antimicrob Agents Chemother; 2001 May; 45(5):1493-9. PubMed ID: 11302816
[TBL] [Abstract][Full Text] [Related]
4. Optimizing topical antifungal therapy for superficial cutaneous fungal infections: focus on topical naftifine for cutaneous dermatophytosis.
Del Rosso JQ; Kircik LH
J Drugs Dermatol; 2013 Nov; 12(11 Suppl):s165-71. PubMed ID: 24196340
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of antifungal efficacy in an optimized animal model of Trichophyton mentagrophytes-dermatophytosis.
Ghannoum MA; Hossain MA; Long L; Mohamed S; Reyes G; Mukherjee PK
J Chemother; 2004 Apr; 16(2):139-44. PubMed ID: 15216947
[TBL] [Abstract][Full Text] [Related]
6. A comparison of the efficacy of oral fluconazole, 150 mg/week versus 50 mg/day, in the treatment of tinea corporis, tinea cruris, tinea pedis, and cutaneous candidosis.
Nozickova M; Koudelkova V; Kulikova Z; Malina L; Urbanowski S; Silny W
Int J Dermatol; 1998 Sep; 37(9):703-5. PubMed ID: 9762826
[No Abstract] [Full Text] [Related]
7. [Dermatomycosis--classification, etiology, pathogenesis, and treatment].
Watanabe S
Nihon Rinsho; 2008 Dec; 66(12):2285-9. PubMed ID: 19069093
[TBL] [Abstract][Full Text] [Related]
8. The use of itraconazole to treat cutaneous fungal infections in children.
Gupta AK; Nolting S; de Prost Y; Delescluse J; Degreef H; Theissen U; Wallace R; Marynissen G; De Doncker P
Dermatology; 1999; 199(3):248-52. PubMed ID: 10592406
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of terbinafine compared to lanoconazole and luliconazole in the topical treatment of dermatophytosis in a guinea pig model.
Ghannoum MA; Long L; Kim HG; Cirino AJ; Miller AR; Mallefet P
Med Mycol; 2010 May; 48(3):491-7. PubMed ID: 20370362
[TBL] [Abstract][Full Text] [Related]
10. Effect of Lamisil and azole antifungals in experimental nail infection.
Richardson MD
Dermatology; 1997; 194 Suppl 1():27-31. PubMed ID: 9154398
[TBL] [Abstract][Full Text] [Related]
11. Mycological Considerations in the Topical Treatment of Superficial Fungal Infections.
Rosen T
J Drugs Dermatol; 2016 Feb; 15(2 Suppl):s49-55. PubMed ID: 26885799
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the therapeutic efficacy of oral doses of fluconazole and itraconazole in a guinea pig model of dermatophytosis.
Nagino K; Shimohira H; Ogawa M; Uchida K; Yamaguchi H
J Infect Chemother; 2000 Mar; 6(1):41-4. PubMed ID: 11810530
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of a rhamnolipid biosurfactant to inhibit Trichophyton rubrum in vitro and in a mice model of dermatophytosis.
Sen S; Borah SN; Kandimalla R; Bora A; Deka S
Exp Dermatol; 2019 May; 28(5):601-608. PubMed ID: 30908723
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of the Efficacy of ME1111 in the Topical Treatment of Dermatophytosis in a Guinea Pig Model.
Long L; Hager C; Ghannoum M
Antimicrob Agents Chemother; 2016 Apr; 60(4):2343-5. PubMed ID: 26833160
[TBL] [Abstract][Full Text] [Related]
15. Lactoferrin given in food facilitates dermatophytosis cure in guinea pig models.
Wakabayashi H; Uchida K; Yamauchi K; Teraguchi S; Hayasawa H; Yamaguchi H
J Antimicrob Chemother; 2000 Oct; 46(4):595-602. PubMed ID: 11020258
[TBL] [Abstract][Full Text] [Related]
16. [In vitro study, in vivo testing and clinical experience with the local antimycotic agent Ovis].
Füller H; Müller J; Marinis S
Med Welt; 1969 Aug; 32():1746-8. PubMed ID: 5801061
[No Abstract] [Full Text] [Related]
17. Clinico-mycological study of dermatophytic infections and their sensitivity to antifungal drugs in a tertiary care center.
Mahajan S; Tilak R; Kaushal SK; Mishra RN; Pandey SS
Indian J Dermatol Venereol Leprol; 2017; 83(4):436-440. PubMed ID: 28540871
[TBL] [Abstract][Full Text] [Related]
18. A novel mycological analysis valuable for evaluating therapeutic efficacy of antimycotics against experimental dermatophytosis in guinea pigs.
Majima T; Masui S; Uchida K; Yamaguchi H
Mycoses; 2005 Mar; 48(2):108-13. PubMed ID: 15743427
[TBL] [Abstract][Full Text] [Related]
19. Topical nitric oxide releasing nanoparticles are effective in a murine model of dermal Trichophyton rubrum dermatophytosis.
Mordorski B; Costa-Orlandi CB; Baltazar LM; Carreño LJ; Landriscina A; Rosen J; Navati M; Mendes-Giannini MJS; Friedman JM; Nosanchuk JD; Friedman AJ
Nanomedicine; 2017 Oct; 13(7):2267-2270. PubMed ID: 28712918
[TBL] [Abstract][Full Text] [Related]
20. Effective treatment of tinea corporis due to Trichophyton mentagrophytes with combined isoconazole nitrate and diflucortolone valerate therapy.
Czaika VA
Mycoses; 2013 May; 56 Suppl 1():30-2. PubMed ID: 23574023
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
